{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:13:29Z","timestamp":1789517609838,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.neo.2020.06.007","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T18:04:13Z","timestamp":1594058653000},"page":"390-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Ex vivo assessment of targeted therapies in a rare metastatic epithelial\u2013myoepithelial carcinoma"],"prefix":"10.1016","volume":"22","author":[{"given":"Rami","family":"M\u00e4kel\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Arjonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldwin","family":"Suryo Rahmanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville","family":"H\u00e4rm\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Lehti\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3503-4094","authenticated-orcid":false,"given":"Teijo","family":"Kuopio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Helleday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0316-0195","authenticated-orcid":false,"given":"Olle","family":"Sangfelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0157-2137","authenticated-orcid":false,"given":"Juha","family":"Kononen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha K.","family":"Rantala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2020.06.007_b0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF00543554","article-title":"Diagnosis and ultrastructure of the tubular carcinoma of salivary gland ducts: epithelial-myoepithelial carcinoma of the intercalated ducts [in German]","volume":"356","author":"Donath","year":"1972","journal-title":"Virchows Arch A Pathol Pathol Anat"},{"issue":"4","key":"10.1016\/j.neo.2020.06.007_b0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/0194599815594788","article-title":"Epithelial-myoepithelial carcinoma of the salivary glands: an analysis of 246 cases","volume":"153","author":"V\u00e1zquez","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.neo.2020.06.007_b0015","first-page":"391","article-title":"Salivary gland epithelial-myoepithelial carcinoma: behaviour, diagnosis and treatment","volume":"7","author":"Senis-Segarra","year":"2002","journal-title":"Med Oral"},{"key":"10.1016\/j.neo.2020.06.007_b0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.pas.0000213314.74423.d8","article-title":"Epithelial-myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract","volume":"31","author":"Seethala","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.neo.2020.06.007_b0025","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/PAS.0b013e318160852a","article-title":"Sebaceous epithelial-myoepithelial carcinoma of the salivary gland: clinicopathologic and immunohistochemical analysis of 6 cases of a new histologic variant","volume":"32","author":"Shinozaki","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.neo.2020.06.007_b0030","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1200\/JCO.1987.5.6.951","article-title":"Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group","volume":"5","author":"Venook","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neo.2020.06.007_b0035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1097-0142(20010201)91:3<541::AID-CNCR1032>3.0.CO;2-Y","article-title":"Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies","volume":"91","author":"Airoldi","year":"2001","journal-title":"Cancer (Phila.)"},{"key":"10.1016\/j.neo.2020.06.007_b0040","first-page":"236a","article-title":"Phase II trial of paclitaxel in advanced or metastatic salivary gland malignancies: an Eastern Cooperative Oncology Group Study","volume":"20","author":"Jennings","year":"2001","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"10","key":"10.1016\/j.neo.2020.06.007_b0045","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of Ras mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2020.06.007_b0050","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1200\/jco.2012.30.15_suppl.5554","article-title":"Expression and prognostic significance of directed therapy targets and mutational analysis of the EGFR pathway in malignant salivary gland tumors","volume":"30","author":"Cros","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neo.2020.06.007_b0055","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12105-013-0506-4","article-title":"HRAS mutations in epithelial-myoepithelial carcinoma","volume":"8","author":"Chiosea","year":"2014","journal-title":"Head and Neck Pathol"},{"issue":"4","key":"10.1016\/j.neo.2020.06.007_b0060","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2019.06.016","article-title":"Personalized drug sensitivity screening for bladder cancer using conditionally reprogrammed patient-derived cells","volume":"76","author":"Kettunen","year":"2019","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.neo.2020.06.007_b0065","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.21873\/anticanres.13791","article-title":"Clonal evolution of MEK\/MAPK pathway activating mutations in a metastatic colorectal cancer case","volume":"39","author":"Lehtomaki","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.neo.2020.06.007_b0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.lungcan.2020.04.036","article-title":"Image-based ex vivo drug screen to assess targeted therapies in recurrent thymoma","volume":"145","author":"Arjonen","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.neo.2020.06.007_b0075","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/S1470-2045(15)00396-4","article-title":"Research methods to change clinical practice for patients with rare cancers","volume":"17","author":"Billingham","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.neo.2020.06.007_b0080","series-title":"The Mathematical Theory of Communication","author":"Shannon","year":"1963"},{"key":"10.1016\/j.neo.2020.06.007_b0085","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"issue":"71","key":"10.1016\/j.neo.2020.06.007_b0090","doi-asserted-by":"crossref","DOI":"10.3791\/50011-v","article-title":"Stampfer MR. Processing of human reduction mammoplasty and mastectomy tissues for cell culture","author":"Labarge","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1016\/j.neo.2020.06.007_b0095","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2017.166","article-title":"Quantification of sensitivity and resistance of breast cancer cell lines to anti-cancer drugs using GR metrics","volume":"4","author":"Hafner","year":"2017","journal-title":"Sci Data"},{"issue":"7289","key":"10.1016\/j.neo.2020.06.007_b0100","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nature08869","article-title":"Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes","volume":"464","author":"Neumann","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neo.2020.06.007_b0105","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1038\/onc.2012.378","article-title":"Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays","volume":"32","author":"Gujral","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2020.06.007_b0110","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1158\/0008-5472.CAN-08-1385","article-title":"NVPBEZ235, a dual PI3K\/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations","volume":"68","author":"Serra","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2020.06.007_b0115","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1158\/1078-0432.CCR-10-1102","article-title":"Dual inhibition of PI3K and mTORC1\/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemia","volume":"16","author":"Chapuis","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2020.06.007_b0120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cell.2012.02.053","article-title":"Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast","volume":"149","author":"Duncan","year":"2012","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.neo.2020.06.007_b0125","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccell.2014.08.017","article-title":"Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors","volume":"26","author":"Cheung","year":"2014","journal-title":"Cancer Cell"},{"issue":"39","key":"10.1016\/j.neo.2020.06.007_b0130","doi-asserted-by":"crossref","first-page":"42183","DOI":"10.18632\/oncotarget.5619","article-title":"Mutant HRAS as novel target for MEK and mTOR inhibitors","volume":"6","author":"Kiessling","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2020.06.007_b0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2217\/pgs.15.174","article-title":"Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatment","volume":"3","author":"Cheung","year":"2016","journal-title":"Pharmacogenomics"},{"issue":"1","key":"10.1016\/j.neo.2020.06.007_b0140","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13073-016-0366-0","article-title":"A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma","volume":"8","author":"Dela Cruz","year":"2016","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/j.neo.2020.06.007_b0145","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1038\/s41467-018-05729-w","article-title":"Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer","volume":"9","author":"Risom","year":"2018","journal-title":"Nat Commun"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558620301299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558620301299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:07:28Z","timestamp":1761484048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558620301299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1476558620301299"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2020.06.007","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ex vivo assessment of targeted therapies in a rare metastatic epithelial\u2013myoepithelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2020.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}]}}